[Cardiac alterations caused by renal failure]

Christiana Mira Schannwell1

  • 1Klinik für Kardiologie, Pneumologie und Angiologie, Klinikum der Heinrich-Heine-Universität Düsseldorf. schannw@uni-duesseldorf.de

Medizinische Klinik (Munich, Germany : 1983)
|June 29, 2006
PubMed

Insights

Cardiac disease is a major concern for patients with end-stage renal disease. Beyond atherosclerosis, heart abnormalities like hypertrophy and fibrosis contribute to myocardial ischemia in uremia.

Area of Science:

  • Nephrology and Cardiology
  • Uremic Cardiomyopathy

Context:

  • End-stage renal disease (ESRD) patients exhibit high cardiovascular mortality.
  • Accelerated atherosclerosis was the presumed cause of cardiac deaths.
  • Recent studies challenge this assumption, showing myocardial infarction accounts for only 30-50% of cardiac deaths in uremia.

Purpose:

  • To explore additional cardiac abnormalities contributing to myocardial ischemia in chronic uremia.
  • To investigate factors beyond coronary artery disease in uremic cardiac mortality.

Summary:

  • A significant portion (30-40%) of patients with renal insufficiency, angina, and ischemia have normal coronary arteries.
  • This suggests non-atherosclerotic mechanisms are involved in cardiac dysfunction.
  • Structural changes like left ventricular hypertrophy, interstitial fibrosis, and microvascular disease impact myocardial perfusion reserve.

Impact:

  • Highlights the multifactorial nature of cardiac disease in end-stage renal disease.
  • Suggests novel therapeutic targets beyond traditional cardiovascular risk management.
  • Emphasizes the need to investigate cardiac structural and functional changes in uremic patients.

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...